Salzhauer Michael Bristol Myers Squibb CO Call Options Transaction History

Salzhauer Michael

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $145,240 - $159,960	2,000 New	2,000 $52,000
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $338,720 - $492,239	-7,300 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $364,154 - $475,006	-7,400 Reduced 50.34%	7,300 $139,000
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $404,240 - $503,840	8,000 Added 119.4%	14,700 $189,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $101,864 - $117,266	1,700 Added 34.0%	6,700 $97,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $276,150 - $318,700	5,000	5,000 $115,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Salzhauer Michael, based on Form 13F filings with the SEC.

Stay updated on Salzhauer Michael with notifications on news.